A dialysis facility in TX. It ran an operating surplus of 85.4% in FY23 on $4.6M of operating revenue. It held -2,675 days of cash on hand — an Astrelis calculation outside expected range, shown at the chart boundary and ranked in its pool. 3 reporting years are on file, but revenue scale shifts too much between them for a like-for-like trend, so trend context is limited.
Operating margin · FY23
+85.4%
Astrelis calculation · as-filed inputs
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY23)
Days cash on hand · FY23
-2,675d
all sources
Astrelis calculation · as-filed inputs
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY23)
Total operating revenue · FY23
$4.6M
Astrelis calculation · as-filed inputs
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY23)
Total margin · incl. nonoperating · FY23
+85.4%
Astrelis calculation · as-filed inputs
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY23)
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.
Operating margin
+85.4% (FY23)
Operating income ÷ total operating revenue
Astrelis calculation · HCRIS WS G-3
Total margin
+85.4% (FY23)
Net income ÷ total revenue incl. nonoperating
Astrelis calculation · HCRIS WS G-3
Days cash on hand
-2675d (FY23)
Cash & investments ÷ daily operating expense
Astrelis calculation · HCRIS WS G / G-3
Current ratio
Astrelis calculation unavailable — the filed balance sheet does not reconcile as filed (statement values shown unchanged)
Total current assets ÷ current liabilities
Astrelis calculation · HCRIS WS G
Equity financing ratio
Astrelis calculation unavailable — the filed balance sheet does not reconcile as filed (statement values shown unchanged)
Total net assets ÷ total assets
Astrelis calculation · HCRIS WS G
Days in net patient A/R
Astrelis calculation unavailable — the filed balance sheet does not reconcile as filed (statement values shown unchanged)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
Astrelis calculation · HCRIS WS G / G-3
$ in thousands
Line item
FY21
FY22
FY23
Patient revenue
118
454
4,555
Total operating revenue
118
454
4,555
Total operating expenses
480
1,317
667
Operating income
(361)
(863)
3,888
Operating margin %
-305.9%
-190.2%
+85.4%
Other non-operating, net
0
1
1
Net income
(361)
(862)
3,889
Net income %
-304.2%
-189.5%
+85.4%
— = Not reported in source for that year.
HCRIS CMS-265 cost report · $ thousands · FY21–FY23 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
Display states.FY22 · Operating margin: -190.2% — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (beyond ±100%)FY22 · Total margin: -189.5% — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (beyond ±100%)FY21 · Operating margin: -305.9% — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (beyond ±100%)FY21 · Total margin: -304.2% — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (beyond ±100%)FY21 · Days cash on hand: -3,077 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)FY22 · Days cash on hand: -1,301 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)FY23 · Days cash on hand: -2,675 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)
How it operates
quality & operational context · CMS public reporting
The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by provenance class and public source; descriptive context only, never a ranking or adequacy claim. Provenance labels: Reported value is copied from the named public source; Astrelis calculation is a formula applied to unchanged reported inputs, with the formula shown; Illustrative estimate is a benchmark gap, multiplier, or scenario — never a measurement.
Total treatments
1,301
Reported value2023
HCRIS CMS-265
Cost per treatment ($)
512.77
Astrelis calculation2023
HCRIS CMS-265
Net revenue per treatment ($)
3,501
Astrelis calculation2023
HCRIS CMS-265
Trajectory
Cost-report basis · 3 reporting years
Operating margin
Days cash on hand
State context
Texas
County-level statistics: linkage not established— this record's county mapping is not verified in the resolved spine, and we never place a facility in a county by guesswork. State-level context appears here once a state aggregate layer lands.
A facility-specific dollar comparison cannot be calculated because a valid same-year peer pool was not reported. The report still includes all available facility measures, peer benchmarks, and a source-coverage inventory.
Report coverage: Limited Facility Benchmark. 7 of 10 facility measures available from public sources. The report covers the available measures against their peer benchmarks; measures the public record does not carry become findings. Coverage is disclosed here before you reserve, and thin data is never a decline reason. The refund guarantee stands: if we cannot deliver the published scope, you pay nothing.
The Board Briefing
Your facility and its world, board-ready. Measures the public record does not carry become findings, never a decline reason.
$1,000delivered within 2 business days of invoice
Reservation: invoice after coverage confirmation. No payment is collected on this site.
